CouchLMWienM. The role of magnesium-rich foods and magnesium supplementation in diabetes management. Top Clin Nutr. 2007;22(4):349–356. doi:10.1097/01.tin.0000308471.02685.10.
2.
GroberUSchmidetJKistersK. Magnesium in prevention and therapy. Nutrients. 2015;7:8199–8226.
3.
GommersLMHoenderopJGBindelsRJ. Hypomagnesemia in type 2 diabetes: a vicious circle?Diabetes. 2015;65(1):3–13. doi:10.2337/db15-1028.
4.
PhamPCPhamPMPhamSV. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007;2:366–373.
5.
HrubyAMckeownNMSongY. Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge. Nutrients. 2013;5:4990–5011. doi:10.3390/nu5124990.
6.
WahlenAHaenniAJohannsonHE. Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?Diabetes Metab Syndr Obes. 2017;10:151–154.
7.
PetersKEChubbSADavisWA. The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study. Plos One. 2013;8(9): e74355.
8.
SvareA. A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhea: a case report. Cases J. 2009;2:156.
9.
KieboomBCTKiefte de JongJCEijgelsheimM. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis. 2015;66(5):775–782.
10.
FatuzzoPZanoliLScolloV. Review: update on magnesium metabolism. G Ital Nefrol. 2016;33(6):1–13.
11.
LeeCTNgHYLeeYT. The role of calbindin-D28k on renal calcium and magnesium handling during treatment with loop and thiazide diuretics. Am J Physiol Renal Physiol. 2016;310:F230–F236.
12.
TohJWOngEWilsonR. Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterol Rep. 2014;3(3):243–253. doi:10.1093/gastro/gou054.
13.
KimDJXunPLiuK. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care. 2010;33(12):2604–2610.
14.
Guerrero-RomeroFSimental-MendiaLEHernandex-RonquilloG. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: a double-blind placebo-controlled randomized trial. Diabetes Metab. 2015;41:202–207.
15.
VermaHGargR. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet. 2016;1–13. doi:10.1111/jhn.12454.
16.
HrubyAMeigsJBO’DonnellCJ. Higher magnesium intake reduces risk of impaired glucose an insulin metabolism and progression from prediabetes to diabetes in middle aged Americans. Diabetes Care. 2014;37:419–427. doi:10.2337/dc13-1397.
